Avantor, Inc.AVTR

NYSEHealthcareLaboratory Analytical Instruments
Price (close)
$15.25
Market cap
$10.4B
P/E
—
Revenue (TTM)
$6.6B
Net income
-$551.4M
Dividend yield
—
1-year total return
29.5%
Net margin
-8.4%
Revenue growth
-2.0%
Debt / equity
0.68x

What Avantor, Inc. does.

We are a leading global provider of mission-critical products and services to customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials end markets. Our business model is grounded in supporting our customers from discovery to delivery and Avantor is embedded in virtually every stage of the most important research, scale-up and manufacturing activities in the industries we serve.

We work with customers across these sophisticated, science-driven industries that require innovation and adherence to the most demanding technical and regulatory requirements. Our customer-centric innovation model enables us to provide solutions for some of the most demanding applications, and we leverage our comprehensive offering and access to early-stage research to identify and develop content and solutions that ultimately become specified into our customers’ approved production platforms.

We go to market in two primary ways. First, in our channel business, VWR, we distribute consumables and equipment to laboratories around the world. Second, we manufacture proprietary products used in life sciences and medical technology applications.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$6.4B$7.4B$7.5B$7.0B$6.8B$6.6B
Net income$116.6M$572.6M$686.5M$321.1M$711.5M-$530.2M
Free cash flow$868.2M$842.5M$710.2M$723.6M$692.0M$495.0M

More on AVTR.

Figures from Avantor, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.